Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine...

Area of Science:

• Cardiovascular Pathology
• Molecular Genetics
• Oncology

Background:

• Cardiac myxomas are rare tumors, often sporadic but sometimes familial within Carney complex (CNC).
• The genetic underpinnings of cardiac myxoma development remain largely unknown.
• Activating GNAS1 mutations are linked to McCune-Albright syndrome, while PRKAR1A mutations are associated with CNC and familial myxomas.

Purpose of the Study:

• To investigate the presence of GNAS1 and PRKAR1A gene mutations in sporadic cardiac myxomas.
• To determine if sporadic cardiac myxomas share the same genetic mutations as familial forms.

Main Methods:

• Direct sequencing of PCR-amplified tumoral DNA from 29 sporadic cardiac myxomas.
• Analysis focused on detecting activating missense mutations in GNAS1 and inactivating mutations in PRKAR1A.

Main Results:

• No activating mutations in the GNAS1 gene (gsp oncogene) were detected.
• No inactivating mutations in the PRKAR1A gene were found.
• This study represents the largest series of sporadic, isolated cardiac myxomas analyzed for these specific mutations.

Conclusions:

• Sporadic cardiac myxomas do not harbor the GNAS1 or PRKAR1A gene mutations identified in familial cardiac myxomas or related syndromes.
• The molecular pathways leading to sporadic cardiac myxomas likely differ from those in familial forms and Carney complex.